Balentine LLC Gsk PLC Transaction History

Balentine LLC

  • $2.54 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 26, 2022
BUY
$42.05 - $47.77 $721,830 - $820,019
17,166 Added 72.5%
40,843 $1.78 Million
Q2 2022

Aug 15, 2022
BUY
$42.05 - $47.77 $721,830 - $820,019
17,166 Added 72.5%
40,843 $1.78 Million
Q1 2022

Oct 26, 2022
SELL
$40.23 - $47.74 $690,588 - $819,504
-17,166 Reduced 42.03%
23,677 $1.03 Million
Q1 2022

May 06, 2022
BUY
$40.23 - $47.74 $374,541 - $444,459
9,310 Added 64.8%
23,677 $1.03 Million
Q4 2021

Oct 26, 2022
SELL
$38.88 - $45.31 $1.03 Million - $1.2 Million
-26,476 Reduced 64.82%
14,367 $634,000
Q4 2021

Feb 02, 2022
BUY
$38.88 - $45.31 $220,371 - $256,817
5,668 Added 65.16%
14,367 $634,000
Q3 2021

Nov 15, 2021
BUY
$38.79 - $43.16 $124,942 - $139,018
3,221 Added 58.8%
8,699 $332,000
Q2 2021

Aug 16, 2021
BUY
$36.52 - $41.46 $200,056 - $227,117
5,478 New
5,478 $218,000
Q3 2020

Nov 02, 2020
SELL
$38.11 - $42.99 $101,029 - $113,966
-2,651 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$37.87 - $43.58 $100,393 - $115,530
2,651 New
2,651 $108,000
Q4 2019

Sep 02, 2020
SELL
$42.0 - $48.25 $44,982 - $51,675
-1,071 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$39.4 - $42.7 $3,664 - $3,971
-93 Reduced 7.99%
1,071 $43,000
Q1 2019

May 16, 2019
BUY
$38.57 - $42.69 $18,860 - $20,875
489 Added 72.44%
1,164 $49,000
Q3 2018

Nov 14, 2018
SELL
$39.75 - $42.69 $9,738 - $10,459
-245 Reduced 26.63%
675 $27,000
Q2 2018

Aug 14, 2018
BUY
$39.61 - $42.76 $20,399 - $22,021
515 Added 127.16%
920 $37,000
Q1 2018

May 16, 2018
SELL
$36.18 - $40.15 $174,423 - $193,563
-4,821 Reduced 92.25%
405 $16,000
Q4 2017

Feb 14, 2018
SELL
$35.34 - $41.9 $73,330 - $86,942
-2,075 Reduced 28.42%
5,226 $185,000
Q3 2017

Nov 15, 2017
BUY
$39.44 - $41.55 $287,951 - $303,356
7,301
7,301 $296,000

Others Institutions Holding GSK

# of Institutions
20
Shares Held
176K
Call Options Held
0
Put Options Held
0
View Full List

About GSK PLC

GSK Quotes by TradingView
  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email